Two Sigma Advisers
BHVN

Two Sigma Advisers’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Two Sigma Advisers’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-83,600
Closed -$12.2M – 2851
2022
Q2 		$12.2M Sell
83,600
-1,600
-2% -$204K 0.03% 455
2022
Q1 		$10.1M Buy
85,200
+37,400
+78% +$4.66M 0.03% 520
2021
Q4 		$6.59M Buy
47,800
+8,900
+23% +$1.13M 0.02% 652
2021
Q3 		$5.4M Buy
+38,900
New +$4.86M 0.01% 749
2021
Q2 		– Sell
-24,430
Closed -$1.67M – 2846
2021
Q1 		$1.67M Sell
24,430
-52,700
-68% -$4.26M ﹤0.01% 1361
2020
Q4 		$6.61M Sell
77,130
-63,100
-45% -$5.35M 0.02% 720
2020
Q3 		$9.12M Buy
140,230
+23,600
+20% +$1.55M 0.03% 565
2020
Q2 		$8.53M Sell
116,630
-51,500
-31% -$2.74M 0.03% 604
2020
Q1 		$5.72M Sell
168,130
-136,100
-45% -$6.22M 0.02% 662
2019
Q4 		$16.6M Buy
304,230
+43,200
+17% +$2.14M 0.04% 440
2019
Q3 		$10.9M Buy
261,030
+70,100
+37% +$2.96M 0.03% 517
2019
Q2 		$8.36M Buy
190,930
+89,300
+88% +$5.03M 0.02% 645
2019
Q1 		$5.23M Buy
101,630
+84,800
+504% +$3.66M 0.01% 823
2018
Q4 		$622K Buy
+16,830
New +$607K ﹤0.01% 1683

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Two Sigma Advisers's BHVN Position: Q3 2022 in Review

Two Sigma Advisers sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 83,600 shares — an estimated $12.2M sold.

Two Sigma Advisers first reported a position in BHVN in Q4 2018 and held it in 14 quarters. The position peaked at $16.6M in Q4 2019. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Two Sigma Advisers reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 83,600 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $12.2M.
  • Two Sigma Advisers first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2018 and held it in 14 quarters.
  • Two Sigma Advisers's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $16.6M in Q4 2019.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.